Press releases Image EN FR Corporate / 17.06.2026 IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend Read more IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend
Press releases Image EN FR Corporate / 17.06.2026 IBA strengthens its leadership team to support its growth Read more IBA strengthens its leadership team to support its growth
Press releases Image EN FR Corporate / 15.06.2026 IBA – ACQUISITION OF OWN SHARES Read more IBA – ACQUISITION OF OWN SHARES
Press releases Image EN Corporate / 14.06.2026 PanTera issues a clarification regarding statements published in the trade press Read more PanTera issues a clarification regarding statements published in the trade press
Press releases Image EN FR Proton Therapy / 10.06.2026 IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy Read more IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy
Press releases Image EN FR Proton Therapy / 09.06.2026 IBA receives FDA Investigational Device Exemption approval for first ConformalFLASH human clinical study Read more IBA receives FDA Investigational Device Exemption approval for first ConformalFLASH human clinical study
Press releases Image EN FR Corporate / 08.06.2026 IBA – ACQUISITION OF OWN SHARES Read more IBA – ACQUISITION OF OWN SHARES
Press releases Image EN FR Proton Therapy / 08.06.2026 IBA signs contract with a major U.S. academic medical center to install two Proteus®ONE proton therapy solutions Read more IBA signs contract with a major U.S. academic medical center to install two Proteus®ONE proton therapy solutions
Press releases Image EN FR Corporate / 01.06.2026 IBA – ACQUISITION OF OWN SHARES Read more IBA – ACQUISITION OF OWN SHARES
Press releases Image EN FR RadioPharma Solutions / 01.06.2026 IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production Read more IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production
